A better understanding of how host genetics, including NOD2, influence immune-microbe interactions and alter susceptibility to IBD is still a challenge endeavor and potentially essential in order to gradually manifest therapeutic and preventative precision measures [77]. The gene discussed is NOD2; the disease is inflammatory bowel disease.